Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification...

Area of Science:

• Biochemistry and Structural Biology
• Computational Biology and Cheminformatics
• Pharmacology and Drug Discovery

Background:

• G protein-coupled receptors (GPCRs) are crucial in cellular signaling and implicated in numerous diseases.
• Identifying allosteric sites on GPCRs is essential for developing novel therapeutic modulators.
• Existing structural data for GPCRs provides a basis for validating computational approaches.

Purpose of the Study:

• To validate a computational strategy for predicting allosteric binding sites in class A GPCRs.
• To assess the druggability of newly identified putative allosteric sites.
• To provide a tool for facilitating the design of GPCR-targeting drugs.

Main Methods:

• Integration of the residue interaction network (RIN) model and the site identification by ligand competitive saturation (SILCS) method.
• RIN analysis to identify key residues mediating allosteric signaling and receptor dynamics.
• SILCS-Hotspots to evaluate the druggability of predicted allosteric sites.

Main Results:

• The combined RIN and SILCS approach successfully predicted known orthosteric and allosteric binding sites for 18 class A GPCRs with high accuracy.
• Graph spectral analysis confirmed predicted sites are at critical interfaces for coordinating receptor dynamics.
• Numerous novel, druggable allosteric sites were identified across 7 distinct class A GPCRs.

Conclusions:

• The validated computational approach effectively predicts allosteric binding sites on GPCRs.
• This method offers a promising strategy for discovering new drug targets and designing modulators for GPCR-related diseases.
• The identification of novel allosteric sites expands the therapeutic potential for targeting GPCRs.